| TTM
|
5/31/2026
|
5/31/2025
|
5/31/2024
|
5/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
|
-- | -- | -- | -- | -29.8000 |
|
Gross Profit
|
-- | -- | -- | -- | -29.8000 |
| Selling, General and Administrative Expenses
|
-1,076.3530 | -1,121.7770 | -1,009.9760 | -532.2100 | -678.4880 |
|
Exploration Expenses
|
-69.8250 | -29.9290 | -116.4320 | -68.9310 | 0 |
|
Research and Development Expenses
|
-- | -- | -- | -- | 19.1670 |
| Provision Expense/Write-Back
|
-- | -- | -- | -- | 0 |
| Other Income/Expense, Operating
|
-190.4770 | -202.4080 | -219.0830 | -133.1410 | -258.5810 |
|
Operating Income/Expenses
|
-1,336.6550 | -1,354.1140 | -1,345.4910 | -734.2820 | -937.0690 |
|
Total Operating Profit/Loss
|
-1,336.6550 | -1,354.1140 | -1,345.4910 | -734.2820 | -937.0690 |
| Net Investment Income
|
-- | -- | -- | 0 | -28.9990 |
| Irregular Income/Expenses
|
0 | 0 | -194.9850 | 0 | -5.9220 |
|
Non-Operating Income/Expenses, Total
|
0 | 0 | -194.9850 | 0 | -28.9990 |
|
Pretax Income
|
-1,336.6550 | -1,354.1140 | -1,540.4760 | -734.2820 | -966.0680 |
|
Net Income from Continuing Operations
|
-1,336.6550 | -1,354.1140 | -1,540.4760 | -734.2820 | -966.0680 |
|
Discontinued Operations
|
-50.5050 | -69.6300 | -76.3400 | -133.4310 | -142.6760 |
|
Extraordinary Items
|
3.9600 | 3.9600 | 0 | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,383.2000 | -1,419.7840 | -1,616.8160 | -867.7130 | -1,108.7440 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,383.2000 | -1,419.7840 | -1,616.8160 | -867.7130 | -1,108.7440 |
|
Net Income Available to Common Stockholders
|
-1,383.2000 | -1,419.7840 | -1,616.8160 | -867.7130 | -1,108.7440 |
|
Diluted Net Income Available to Common Stockholders
|
-1,383.2000 | -1,419.7840 | -1,616.8160 | -867.7130 | -1,108.7440 |
| Basic EPS
|
-0.07 | -0.08 | -0.34 | -0.30 | -0.40 |
| Diluted EPS
|
-0.07 | -0.08 | -0.34 | -0.30 | -0.40 |
|
Basic Weighted Average Shares Outstanding
|
21,949.3130 | 18,299.2880 | 4,753.3360 | 3,189.1480 | 2,858.0060 |
|
Diluted Weighted Average Shares Outstanding
|
21,949.3130 | 18,299.2880 | 4,753.3360 | 3,189.1480 | 2,858.0060 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,336.6550 | -1,354.1140 | -1,540.4760 | -734.2820 | -966.0680 |
|
EBITDA
|
-1,336.6550 | -1,354.1140 | -1,540.4760 | -707.8880 | -936.2680 |
|
Normalized EBITDA
|
-1,074.5440 | -1,048.1330 | -1,111.7410 | -602.0270 | -771.4610 |
|
Normalized Income
|
-1,074.5440 | -1,048.1330 | -1,345.4910 | -628.4210 | -1,073.8230 |
5/31/2023 - 10/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade